Squarepoint
DSGN icon

Squarepoint’s Design Therapeutics DSGN Stock Holding History

Squarepoint’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$181K Sell
14,393
-15,237
-51% -$211K ﹤0.01% 4101
2026
Q2 		$429K Sell
29,630
-56,487
-66% -$704K ﹤0.01% 3539
2026
Q1 		$916K Buy
86,117
+39,975
+87% +$404K ﹤0.01% 2840
2025
Q4 		$433K Buy
+46,142
New +$361K ﹤0.01% 3325
2025
Q1 		– Sell
-48,186
Closed -$297K – 4770
2024
Q4 		$297K Sell
48,186
-36,945
-43% -$214K ﹤0.01% 4151
2024
Q3 		$458K Sell
85,131
-4,824
-5% -$22.7K ﹤0.01% 3167
2024
Q2 		$301K Buy
89,955
+53,518
+147% +$209K ﹤0.01% 3429
2024
Q1 		$147K Sell
36,437
-1,992
-5% -$5.32K ﹤0.01% 3711
2023
Q4 		$102K Sell
38,429
-4,133
-10% -$9.47K ﹤0.01% 3753
2023
Q3 		$100K Buy
42,562
+972
+2% +$4.53K ﹤0.01% 3556
2023
Q2 		$262K Sell
41,590
-67,624
-62% -$414K ﹤0.01% 3050
2023
Q1 		$630K Buy
+109,214
New +$817K ﹤0.01% 2168
2021
Q2 		– Sell
-23,493
Closed -$702K – 3342
2021
Q1 		$702K Buy
+23,493
New +$792K ﹤0.01% 1776

Other funds holding DSGN

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Squarepoint's DSGN Position: Q3 2026 in Review

Squarepoint reduced its Design Therapeutics (DSGN) stake by 51% in Q3 2026, selling an estimated $211K and leaving 14,393 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #4101.

Squarepoint first reported a position in DSGN in Q1 2021 and has held it in 13 quarters since. The position peaked at $916K in Q1 2026. 68 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.

  • Squarepoint held 14,393 shares of Design Therapeutics worth $181K as of Q3 2026.
  • Squarepoint sold 15,237 Design Therapeutics shares in Q3 2026, an estimated $211K.
  • Design Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4101 holding.
  • Squarepoint first reported a position in Design Therapeutics in Q1 2021 and has held it in 13 quarters since.
  • Squarepoint's Design Therapeutics position peaked at $916K in Q1 2026.
  • 68 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.